SC 13G/A
File 005-89449
AMENDMENT NO. 3 TO THE SCHEDULE 13G
- Filing date
- 14 Feb 2019
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
Syndax Pharmaceuticals Inc reports
- Company location
- New York, NY
- Fiscal year end
- 31 December
Company
Names, identifiers, and filing context for this profile.
1 identity field
SEC filing record 1 source field available
Syndax Pharmaceuticals Inc has filed 653 SEC EDGAR filings since 06 Apr 2007
SEC filing history
Showing 51-70 of 70 matching filings.
Per page
25
Current page
3
SC 13G/A
File 005-89449
FEBRUARY 14, 2019
- Filing date
- 14 Feb 2019
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G/A
File 005-89449
SEC SCHEDULE 13G
- Filing date
- 12 Feb 2019
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G/A
File 005-89449
SC 13G/A
- Filing date
- 12 Feb 2019
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G
File 005-89449
SC 13G filing
- Filing date
- 08 Feb 2019
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G
File 005-89449
THE SCHEDULE 13G
- Filing date
- 29 Nov 2018
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G/A
File 005-89449
AMENDMENT NO. 2 TO THE SCHEDULE 13G
- Filing date
- 14 Feb 2018
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G/A
File 005-89449
SEC SCHEDULE 13G
- Filing date
- 08 Feb 2018
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G/A
File 005-89449
SC 13G/A
- Filing date
- 02 Feb 2018
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G/A
File 005-89449
SC 13G/A filing
- Filing date
- 11 Dec 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G/A
File 005-89449
SC 13G/A filing
- Filing date
- 07 Dec 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G/A
File 005-89449
AMENDMENT NO. 1 TO THE SCHEDULE 13G
- Filing date
- 17 Nov 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G
File 005-89449
THE SCHEDULE 13G
- Filing date
- 14 Nov 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G/A
File 005-89449
SC 13G/A filing
- Filing date
- 14 Feb 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G
File 005-89449
SC 13G
- Filing date
- 09 Feb 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G/A
File 005-89449
SEC SCHEDULE 13G
- Filing date
- 09 Feb 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G
File 005-89449
SC 13G filing
- Filing date
- 30 Jan 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G
File 005-89449
SCHEDULE 13G FOR SYNDAX PHARMACEUTICALS, INC. BY DOMAIN PARTNERS VIII, L.P.
- Filing date
- 09 Jan 2017
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G
File 005-89449
SEC SCHEDULE 13G
- Filing date
- 12 Sep 2016
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G
File 005-89449
SC 13G filing
- Filing date
- 11 Apr 2016
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing